Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2303]
News [5278]
Articles [130]
Editorials [4]
Conferences [158]
elearning [13]
Selecting appropriate first line lung cancer therapy
Dr Paul Bunn - University of Colorado, Denver, USA
Selecting appropriate first line lung cancer therapy ( Dr Paul Bunn - University of Colorado, Denver, USA )
8 Jul 2009
Studying genetics behind drug resistance using cell culture models
Dr René Bernards - Netherlands Cancer Institute, Amsterdam
Studying genetics behind drug resistance using cell culture models ( Dr René Bernards - Netherlands Cancer Institute, Amsterdam )
8 Jul 2009
Targeting death receptors in chemo-resistant cancer cells
Prof Patrick Johnston - Queen's University Belfast, UK
Targeting death receptors in chemo-resistant cancer cells ( Prof Patrick Johnston - Queen's University Belfast, UK )
3 Jul 2009
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast...
Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer ( Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US )
3 Jul 2009
AACR 2009: Tackling the p53 gene and side effects
Professor David Lane - Director of the Cancer Research UK Transformation...
AACR 2009: Tackling the p53 gene and side effects ( Professor David Lane - Director of the Cancer Research UK Transformation Research Group, University of Dundee )
18 May 2009
AACR 2009: Chemokine inhibitors to prevent tumour growth
Prof Alberto Mantovani - Professor of General Pathology, University of Milan
AACR 2009: Chemokine inhibitors to prevent tumour growth ( Prof Alberto Mantovani - Professor of General Pathology, University of Milan )
14 May 2009
AACR 2009: Preclinical Analysis of Combined PI3K and MEK Inhibition as a...
Dr Lori Friedman - Director, Cancer Signalling and Translational Oncology...
AACR 2009: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strategy for the Treatment of Cancer ( Dr Lori Friedman - Director, Cancer Signalling and Translational Oncology, Genentech )
30 Apr 2009
Effects of Myelodysplastic Syndrome
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease...
Effects of Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009
Clinical research needs better interpretation
Professor Aron Goldhirsch, Director of the Department of Medicine at the...
Clinical research needs better interpretation ( Professor Aron Goldhirsch, Director of the Department of Medicine at the European Institute of Oncology )
12 Jan 2009
Professor José Baselga, ESMO and Professor Martine Piccart, BIG
IMPAKT Conference - Exclusive preview
Professor José Baselga, ESMO and Professor Martine Piccart, BIG ( IMPAKT Conference - Exclusive preview )
9 Jan 2009
Tailored Therapy - Increase Efficacy of Cetuximab
Erbitux and the KRAS Mutation
Tailored Therapy - Increase Efficacy of Cetuximab ( Erbitux and the KRAS Mutation )
28 Nov 2008

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation